New Breast Cancer Patient Resource Is Available

Publication
Article
Oncology NEWS InternationalOncology NEWS International Vol 5 No 11
Volume 5
Issue 11

WILMINGTON, Del-The Breast Cancer Patient Education Service, recently established by Zeneca Pharmaceuticals, allows breast cancer patients and their families to obtain patient education materials on tamoxifen (Nolvadex) with one phone call.

WILMINGTON, Del—The Breast Cancer Patient Education Service, recently established by Zeneca Pharmaceuticals, allows breast cancer patients and their families to obtain patient education materials on tamoxifen (Nolvadex) with one phone call.

The service provides the Progress for Life educational package, which includes written materials explaining breast cancer issues in easy-to-understand language and a video featuring experts on tamoxifen treatment, as well as useful toll-free numbers for other breast cancer information resources.

Patients can access the service by calling 1-800-34-LIFE-4 (1-800-345-4334), Monday through Friday, 8:15 AM until 4:30 PM Eastern Standard Time.

Recent Videos
Regardless of disease burden or disease progression speed on front-line therapy, trastuzumab deruxtecan appears effective in HER2-low breast cancer.
Performance status, age, and comorbidities may impact benefit seen with immunotherapy vs chemotherapy in patients with breast cancer.
Related Content